ACTA2 expression predicts survival and is associated with response to immune checkpoint inhibitors in gastric cancer. Park S, Karalis JD, Hong C, Clemenceau JR, et al. Clin Cancer Res 2022 Dec 12:CCR-22-1897. doi: 10.1158/1078-0432.CCR-22-1897.

Read + Share

Amedeo Smart

Independent Medical Education

Park S, Karalis JD, Hong C, Clemenceau JR, et al. ACTA2 expression predicts survival and is associated with response to immune checkpoint inhibitors in gastric cancer. Clin Cancer Res 2022 Dec 12:CCR-22-1897. doi: 10.1158/1078-0432.CCR-22-1897.
PMID: 36508166